First Responder Wellness Summit: Caring for Ourselves During the Overdose Crisis
This free one-day summit brings together professionals from law enforcement, fire, EMS, corrections, co-response teams, dispatch, and peer support to explore how to strengthen first responder well-being amidst the current drug overdose crisis and in their lives more broadly.
Learn more about the speakers and breakout options here.
We have limited parking assistance funds available. If parking on campus would present a barrier to your attendance please indicate this during registration. Assistance will be provided on a first-come, first-served basis.
Contact nbranche@uw.edu for questions or for accommodation requests.
Event interval: Single day event. Accessibility Contact: Nicole Branche, nbranche@uw.edu. Event Types: Conferences.
Wednesday, September 23, 2026, 8:00 AM – 3:45 PM.
UW Student Union Building (HUB)
HUB Ballroom
4001 E. Stevens Way NE
Seattle, WA 98195.
For more info visit adai.uw.edu. Stabilizing High-Risk Pregnancy in OUD: A Two-Part Webinar on Inpatient Care (Part 1)
Opioid use disorder (OUD) in pregnancy is a high-risk pregnancy, and inpatient admission can be an appropriate, medically necessary means of stabilizing it. This two-part webinar presents both the clinical rationale for these stabilizing admissions and a practical framework for delivering them.
Part 1 establishes the clinical foundation, examining the maternal, obstetric, and neonatal risks associated with OUD in pregnancy; the role of medication for opioid use disorder (MOUD) in mitigating those risks; and the indications and medical necessity for admission. It also addresses a reimbursement misconception: that such admissions are made "to initiate MOUD," rather than to stabilize a high-risk pregnancy.
Part 2 translates this foundation into practice. In a moderated panel discussion, experienced clinicians share how stabilizing admissions are carried out across a range of care settings, offering case examples and lessons learned.
• Part 1: September 23 (12pm PT): Clinical Considerations for Admission
• Pa…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Target Audience: This series is intended for clinicians and health system professionals involved in the care of pregn.
Wednesday, September 23, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration.
Mindfulness-Based Relapse Prevention for Addictive Behavior
Presenters: Neha Chawla, PhD, Joel Grow, PhD, and Erinn McGraw, BFA (University of Washington)
Mindfulness-based approaches to the treatment of addictive behavior invite greater awareness of triggers, cravings, habitual patterns, and automatic reactions. This cultivates the capacity to pause, observe present-moment experience with openness and curiosity, and respond with greater flexibility and choice.
This workshop will introduce participants to the core practices and exercises that illustrate the intentions and foundations of Mindfulness-Based Relapse Prevention (MBRP). Throughout the workshop, participants will explore how mindfulness can help clients relate differently to difficult thoughts, emotions, and urges, supporting recovery and reducing vulnerability to relapse.
Participants will leave with a foundational understanding of MBRP principles and direct experience with several core practices.
Attendees will also learn about a new online MBRP course developed by the presenters on behalf of the North…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_t6rJX0zDSJmoknSq-cMKUw. Accessibility Contact: Meg Brunner meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, September 30, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_t6rJX0zDSJmoknSq-cMKUw.
Kratom and 7-OH: What are they? Why do people use them? What are other options?
Kratom and 7-OH products are unregulated drugs sold as supplements that people buy online or in smoke shops or gas stations. Kratom’s main components, mitragynine, 7-OH (7-hydroxymitragynine), and related substances, are opioids.
These drugs are of growing concern due to their potential for addiction and overdose, and wide availability. On August 26, 2026, the DEA made the sale and possession of three 7-OH related compounds by the general public illegal. However, simply banning these products may have unintended consequences.
In this webinar you will learn:What are kratom and 7-OH products? What are the health effects? How do they compare with other drugs? What are the different reasons people use kratom and 7-OH? How to talk to people about their kratom and 7-OH use and what are other options, Potential unintended consequences of kratom and 7-OH bans, Speakers: Mark Duncan, MD, Associate Professor, Director, Division of Addictions, Department of Psychiatry and Behavioral Sciences, UW
Caleb…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_eNHaIS8qTHitz5RhRli-lQ. Accessibility Contact: Meg Brunner meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, October 7, 2026, 1:00 PM – 2:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_eNHaIS8qTHitz5RhRli-lQ.
Stabilizing High-Risk Pregnancy in OUD: A Two-Part Webinar on Inpatient Care (Part 2)
Opioid use disorder (OUD) in pregnancy is a high-risk pregnancy, and inpatient admission can be an appropriate, medically necessary means of stabilizing it. This two-part webinar presents both the clinical rationale for these stabilizing admissions and a practical framework for delivering them.
Part 1 establishes the clinical foundation, examining the maternal, obstetric, and neonatal risks associated with OUD in pregnancy; the role of medication for opioid use disorder (MOUD) in mitigating those risks; and the indications and medical necessity for admission. It also addresses a reimbursement misconception: that such admissions are made "to initiate MOUD," rather than to stabilize a high-risk pregnancy.
Part 2 translates this foundation into practice. In a moderated panel discussion, experienced clinicians share how stabilizing admissions are carried out across a range of care settings, offering case examples and lessons learned.
• Part 1 September 23 (12pm PT): Clinical Considerations for Admission
—Prese…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Target Audience: This series is intended for clinicians and health system professionals involved in the care of pregn.
Wednesday, October 21, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration.
Therapeutic Potential of GLP-1 Receptor Agonists for Substance Use Disorders (1.5 CME available!)
Presenter: Christian Hendershot, PhD, Keck School of Medicine, University of Southern California (read more about Dr. Hendershot here)
This presentation will summarize emerging evidence for the efficacy of GLP-1 receptor agonists for substance use disorders. Recent and ongoing Phase 2 clinical trials will be reviewed, and key clinical and implementation issues discussed.
Learning objectives
Participants will be able to:
Identify at least three (3) potential therapeutic benefits of GLP-1-based therapies for individuals with substance use disorder. Describe at least three (3) common side effects and three (3) safety considerations for GLP-1-based therapies. Explain at least three (3) GLP-1-based therapies currently under evaluation for substance use disorder. 1.5 CE/CME available! Download our flyer to learn more about CME/CE accreditation.
Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network.
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_FaWdFAwWR1ChXJ3i1iPuGg. Accessibility Contact: Meg Brunner meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, October 28, 2026, 11:00 AM – 12:30 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_FaWdFAwWR1ChXJ3i1iPuGg.
Frontline Conversations Series: 7-OH: Treatment Considerations for the New, More Potent Kratom
Join this 4-part webinar series, Frontline Conversations: Advancing SUD Care in Clinical Practice, facilitated by Mark Duncan, MD and Maureen Oscadal, RN, MPH, BSN, to explore emerging practices in the care of people living with substance use disorder (SUD).
This series features brief presentations and panel discussions with expert community providers on the topics listed below. A Q&A session for all participants will take place after the facilitated discussion.
November 4, 2026: 7-OH: Treatment Considerations for the New, More Potent Kratom
Panelists TBD!
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, November 4, 2026, 12:00 PM – 1:30 PM.
Webinar - register at: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration.